browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
b2c728e8-3979-4769-83d1-af8aa161da4c
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:01:34
Income (reported)
$60,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

THE MCMANUS GROUP

Consulting

Contact
NATE GASPAR
Phone
+1 434-989-7548
Address
zip:20001, city:Washington, state:DC, street:610 10th St. NW Suite 300
Client

AMGEN

State
DC
Country
US
Government-entity client
false
Effective date
2007-08-09
Issues lobbied + lobbyists (1)

MMM — Medicare/Medicaid

Access and reimbursement for Part B and Part D drugs. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement under Medicare Part B drugs. Policies related to the Most Favored Nation Drug Pricing Model

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.